These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1716412)

  • 21. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA.
    Budke H; Orazi A; Neiman RS; Cattoretti G; John K; Barberis M
    Mod Pathol; 1994 Oct; 7(8):860-6. PubMed ID: 7838840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.
    Hepburn PJ; Glynne-Jones E; Goddard L; Gee JM; Harper ME
    Histochem J; 1995 Mar; 27(3):196-203. PubMed ID: 7797424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and experimental studies on the cellular kinetics in esophageal carcinoma by using monoclonal antibody KI-67].
    To Y
    Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):341-51. PubMed ID: 8321181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections.
    Key G; Petersen JL; Becker MH; Duchrow M; Schlüter C; Askaa J; Gerdes J
    J Clin Pathol; 1993 Dec; 46(12):1080-4. PubMed ID: 7506714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in proliferation markers in colorectal cancer.
    Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
    Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A closer look at the cell cycle.
    Kreipe H; Parwaresch R
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):341-3. PubMed ID: 8391734
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cytometric systems.
    Kennedy JC; el-Badawy N; DeRose PB; Cohen C
    Anal Quant Cytol Histol; 1992 Aug; 14(4):304-11. PubMed ID: 1388567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of cell cycle analysis by propidium-iodine staining of CD56+ cells in pediatric brain tumors.
    Vartholomatos G; Alexiou GA; Stefanaki K; Lykoudis EG; Tseka G; Tzoufi M; Sfakianos G; Prodromou N
    Clin Neurol Neurosurg; 2015 Jun; 133():70-4. PubMed ID: 25867234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of (S+G2)-phase fractions determined by flow cytometry and Ki-67 labelling indices in colorectal carcinomas.
    Zölzer F; Gilbertz K; Streffer C
    Oncology; 1994; 51(1):9-12. PubMed ID: 8265111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT; Weiss MH; Law RE; Hinton DR
    J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
    Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidine labeling index versus Ki-67.
    Meyer JS
    Am J Clin Pathol; 1991 Apr; 95(4):602-4. PubMed ID: 2014789
    [No Abstract]   [Full Text] [Related]  

  • 36. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
    Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
    Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
    Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
    J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of the proliferative activity of hepatocellular carcinoma with the monoclonal antibody Ki-67 using flow cytometry].
    Watanabe S
    Nihon Geka Gakkai Zasshi; 1995 Jul; 96(7):439-47. PubMed ID: 7675023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the MIB-1 antibody for detecting proliferating cells in the retina.
    Geller SF; Lewis GP; Anderson DH; Fisher SK
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):737-44. PubMed ID: 7890504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas.
    Sabattini E; Gerdes J; Gherlinzoni F; Poggi S; Zucchini L; Melilli G; Grigioni F; Del Vecchio MT; Leoncini L; Falini B
    J Pathol; 1993 Apr; 169(4):397-403. PubMed ID: 8099126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.